Category: fda

KFF Health News’ ‘What the Health?’: Less Than Two Weeks To Go

With Election Day rapidly approaching, abortion is gaining traction as a voting issue, according to public opinion polls. Meanwhile, states with abortion bans are reviving the lawsuit — dismissed by the Supreme Court on a technicality this year — that could roll back the availability of the abortion pill mifepristone. Sarah Karlin-Smith of the Pink Sheet, Rachel Cohrs Zhang of Stat, and Victoria Knight of Axios join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Tricia Neuman, senior vice president of KFF and executive director of its Program on Medicare Policy, about Medicare open enrollment and the changes to the federal program for 2025.

Poppy Seed Brew Triggers Morphine Overdose, Drawing Attention of Lawmakers

Poppy seeds contaminated with opioids can be used to make a deadly brew, a watchdog says.

FDA’s Promised Rules on Pulse Oximeters Unlikely To End Decades of Racial Bias

For decades, the pulse oximeters used in hospitals, ambulances, and homes have underestimated the oxygen needs of darker-skinned patients. The FDA is preparing guidelines to fix that. But will the new rules go far enough?

Setting the Record Straight on the FDA’s Authority Over Drug Ads

KFF Health News gives readers a chance to comment on a recent batch of stories.

The FDA Calls Them ‘Recalls,’ Yet the Targeted Medical Devices Often Remain in Use

With medical devices, recalls are not always what they seem. In some recalls, including some of the most serious, the FDA and the manufacturers let doctors and hospitals continue to use the devices.

Inside Project 2025: Former Trump Official Outlines Hard Right Turn Against Abortion

Former President Donald Trump has distanced himself from a Heritage Foundation document that outlines positions on abortion and a range of other social issues. But Democrats view it as a window into the far right’s to-do list and a clear opening for political attack.

The CDC’s Test for Bird Flu Works, but It Has Issues

The Centers for Disease Control and Prevention promises better tests are in the works, but the episode points to vulnerabilities in the country’s defense against emerging outbreaks.

Why Millions Are Trying FDA-Authorized Alternatives to Big Pharma’s Weight Loss Drugs

Although Novo Nordisk and Lilly lump together the pharmacies that compound semaglutide and tirzepatide with internet cowboys selling fake drugs, there is a distinction. The FDA has offered Americans little clarity about the vast gray and black markets for the drugs.

From Dr. Oz to Heart Valves: A Tiny Device Charted a Contentious Path Through the FDA

The story of MitraClip, a device Dr. Oz helped invent to treat faulty heart valves, is a cautionary tale about the science, business, and regulation of medical technology.

KFF Health News’ ‘What the Health?’: SCOTUS Term Wraps With a Bang

The Supreme Court has issued its final opinions for the 2023-24 term, including decisions affecting abortion access, the opioid epidemic, and how the federal government functions. In this special episode, Sarah Somers , legal director of the National Health Law Program, joins KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss how the justices disposed of the term’s health-related cases and what those decisions could mean going forward.